Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**HOXB cluster antisense RNA 2 (HOXB-AS2)** is a long non-coding RNA (lncRNA) encoded within the HOXB gene cluster, overlapping the HOXB3 locus on the antisense (reverse) strand.[3] It is classified as a natural antisense transcript (NAT RNA). While some HOX cluster lncRNAs such as HOXA-AS2 and HOXA-AS3 are involved in cancer cell proliferation, apoptosis, and other regulatory pathways, the specific biological function of HOXB-AS2 remains poorly characterized. HOXB-AS2 has been proposed to play a regulatory role in gene expression and has been suggested to be *potentially* involved in the development of atrial fibrillation, but detailed mechanisms and targetability data are lacking.[3] It is not currently recognized as a validated therapeutic target and no drugs are reported to target HOXB-AS2. **Summary of interpretation:** - The most likely interpretation of your query is that you are interested in "HOXB-AS2," not "HOXA-AS2"—these are distinct lncRNAs from different HOX clusters. The available data specific to HOXB-AS2 is very limited, in contrast to HOXA-AS2, which is better studied in cancer biology.[1][2][3][4] If you intended HOXA-AS2, please clarify, as much more information is available. - HOXB-AS2 is not a receptor, enzyme, or characterized drug target; it is a lncRNA whose precise function and disease associations are still largely unknown. There are no known drug interactions, biomarkers, or detailed safety concerns reported in the literature.[3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HOXB cluster antisense RNA 2 (HOXB-AS2).